Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e. Tuesday, 03rd November, 2026 have 1. Approved the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026 along with the Limited Review Report issued by the Statutory Auditors of the Company enclosed herewith. 2. Discussed the upgradation project of manufacturing facility for compliance with Revised Schedule M.

lsHITA DRUGS & INDUSTRIES LTD. C®rp. Offi: 401, 3rd i)re 11, Opp. Parimal Garden. C. G. Road. Ahmedabad-380006. Reed. Office & Factory : 179/I, \fasna-lyava, Tat, Sanand, Disc, : Ahmedabad. E-mall : ishitadrLizs@mall.com I lnfo@lshltadrugs.com I URL : www.ishitadmuf!s.com Phone : +917226995613/I +9179 4002 3839 Date: 03.112026 The Department of Corporate Services, BSE Limited. Floor No. 25, Phiroze Jeejeebhoy Towers, Dalal Street; Mumbai-400001. Scrin Code: 524400 Dear Sirwadarty Snt].Iect: Otltcome of Board Mechng LLe]d on 03rd November, 2026 Pursuant to the regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of Ishita Drugs and Industries I :mited, at its meeting held today i.e. Tuesday, 03rd November., 2026 have 1. Approved the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026. We enclosed herewith the Limited Review Report of the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026 issued by the Statutory Auditors of the Company. 2. Discussed the upgradation project of manufacturing facility for compliance with Revised Schedule M. TThe Managing Director updated the Board on the status of the upgradation project. The civil work, planned under the current phase, is nearing completion. Till date, the Company has spent neariy Rs. 488 lakh towards renovation of existing buildings and constrilction of new blocks. Further, deliveries of some equipments, ordered in previous months, have started. Simultaneously, various agencies are working at the site, for the electrical, piping and HVAC work. The Company, has so far made payments towards such capital expenditure, by way of advances and against invoices, to the extent of Rs. 190 lakh. This has been fininced partly by availing disbursement of term loan of Rs. 51.90 lakh from HDFC Banl¢ against total sanctioned loan of Rs. 975 lakh. The meeting commenced at 04.30 p.in. and concluded at 05.10 p.in. Please take the above details on your records. T-YOU For, Ishita Drugs and Industries Limited ]agdish Agrawa] Managing Director DIN:01031687 •our6asodruasinthesricelfharmanri/uiorawidt CIN No. L24231GJ1992PLC017054 D a a D-U-N-S Number . 65J318-0359 Office Address : EJl 5, Sumol liilsinoss harli . 7. : a(-== Soni in chawl, Alimedal]ad . 380026. Date: 03/11/2026 The Board of Directors, lshita Drugs & Industries limited, Ahmedabad. ELM_I_TEDREvltwREPORT We have reviewed the accompanyln8 of unaudited flnanclal resvlts of lsHn-A DRUGS AND INDLJSTRIES LIMITED for the period 01 Jul Z026 to ae Sep 2026. IThe Statement) being submitted by the Company pursuanttothereqliirementOfRegulation33ofSEBI(ustln€ofObligationandDisclosureRequirements) Regulation,2015IeadwithSEBICircularNo.ClfycfD/FAC/62/2016dated5thJuly,2016.Thisstatementis theresponsibilityOftheConipany'sManagementandhasbeenapprovedbythefroardofDlrectors.Our responsibilityistoissueareportontheseflnancialstatementsbasedonourrevlew. WeConductedourreviewinaccordancewiththeStandardonReviewEngagemerlt(SRE)2410,Reviewof %amrtfiern:nd#:TngT;n,#a:#st¥nTaer:nrdL#rn:et#a:uwdeitpTa#atnt::##t#,etryviethwet,:#: moderateassuranceastowhetherthefinancialstatementsaretreeofmaterlalmlsstatement.AIeviow isIimitedPrimarilytoinquiriesOfcompanypersonnelandanalvtlcalprocediiresappliedtofinancialdata andthuspfovidelessassiirancethananaudlt.wehavenotperformedanaudltandaccordlngly,Wedo not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial iesults prepared in accordance with Indian accounting standards prescl.ibe under section 133 of companies Act,2013 read with relevant rules issued there under and anotl`er recognized accounting practices and policies has not dlsdosed the information required to be disclosed in terms of Regulation 33 Of SEBl (listing of obllgation and Disclosure Requirements) Regulation, 2015 read with SEBI Circular No. CIR/CFD/FAC/62/2016 dated 5th July, 2016 includingthemannerinwhichitistobedisclosed,orthatitcontalnsanymaterialmisstatement. UDIN: 26170863RTQZQM8352 , Cor|i. Offic. : 410411. Lillmani Corpor®t.11®iolit8, O|ip. mmapir Brt3,Bus Swhd, «r. Ozou. Aonoait, How W.dej, AIIm.detiad 1380013, Glij.rut n CA Movank S.nclieti +918000331632 / 7048685472 - camavaltLeancltcti©gm8il.com • GST" : 24AA0I:Jl119RIZY LL'iZ a=IJ|: 38IteIL XEE96 ®E8Ca,J=6 3C:gi:aIa XF!i2€C) f9aIatiE !9:IIg: 9iaE€a,JIgg! I£t®aIIICL Ei®Ig®iai i;1a'C)E`a01,91a,a g£.Ei! Ea.SZ CLa:Z SIaa a,aE ®=aaC.93`E0E<1C=a,Ia 8IJ±fEao ¥CLiiE;u\`i;C'a|Ja'IIi5a, =IA1=J =a=Ea£!a.i IIii€3±Eia =aaIa,JIE?Ii£a£- IE8et59!IariXE a'ai;III8IE€?J!-?. i:£|JI0= #EaJE=6 ae1=0§ ifJ=i ?IiIXF® .IECL£¥a, XJPg£Ia I0=aaaa,I Xj=£a=.9= 6±Ej3gauE:aIIE Ita:J I BILL|0€a=0, u a) ae . C =h t E\8 =i . 8e . V a) 9® . 8e . i±aIICI,iO v,I=a=in 1=iEJ Illi0• i;ILL| V +2® 0 e0n i5 n i Va ) t= - 00 0!, t e`.= t elqI+ C C) )a ; q. a aa e «.a C a)e C C)c )> a ac> Eai;I =?=in II:J ®IaI*P§gi :® . ®inc> incOt` EIIEI i;ILL|0EIa=10 t a- v g). a S5 c 8o. t 0o \. V a) e §. q €D e a. a® e. e a. :IIIJ !uJ=Ea=® LI,18 uJ!Ci;I0E< v a). S ScO t 0< 0r, 8 V, v a5 §e . #= . c 8' 8c,c EaI~tl U,a,1tiE!a,iLPg 1 E=a £i90I i3IILL,0 tnrtyd g:I-® 00OnaH cOao® t-aa ttcOt= aac, cOrv 9IU,iEiE aii;ff.aiE5a,a J36£aC|Ji= E=gai;#ai =dIOn.aIEa9EE j=1€=J=U,.aJtJuaIIg gC=,5iIu%an! a'5#=a'C]i)a,3S80 an,£#g8'E#I:a,a :9!a'ffCatiEa'Da'a=±E£g 5a6=I:U).aIEi;a,I58I: 0CEa=3Si#89? 8a'iiJ=!85ai g8a'rIaa)I9£BiJ=|L'i3£ €9ai;g5e0J2j3IA¥0aaaE1 =?EI£I8e=Iani®IE 0)IaiaEIIi?Ie90IU,iIiaLL' €9!toE:8IaEeaI)jBJB=®8`-8ECLE 8±J)gI??E30EeaEaI90a!i I0=aaIJCEaE£gaJ=a¥-?IE.9= Ea=aatoIIII8E€gdJJ=gi:-toIE&I9IC) IaEa'aai:JEE!iE€g11,J=a,aa£-9EEu£ IaEia|J®IIE8|JE€90I0a'CL3±?I0Ill|J€C) :±E0i8IE5Ei€i J2|J9CI30e:JE9EaIIa£u8a,€#:::'5I:.==3gE0=5a£\!a! 9£i5a,1=a'E!9Ij!2a.E80I5 a1i5=a'C5aI9a'J€JJt3I,i!i£€®E:9I=e!ai€ =a'I5a'I9a'IJEIJ2ii;a'C1a,:?i:i€ iai;III?IqEa¥IgE8E9gn)Iai:-Pi0uJa iL0|J®IIE8ttI000IiI.E8i€=i:niai-PiJEi¥C} I+I-a i=c> cOic) cOaa 00ia cOtta a.tlr` aC>a aac) 0C>c> lslilTA DRUGS AND INDUSTRIES LIIVIITED aN:i2423iGiiggzpicoi:7o54 Registered Office: Survey No. 179/1, Village : Vasna-Iyava, Ta. Sanand Atlmedabad - 382170 Website: w`An^/.ishitadrugs.com Contact: +91 7226995613/14/15 Statement of Assets and Liabilities Amount in Lakhs Half Year Ended Previous year Ended 6 Months Ended 1Z Months Ended Particulars unaudlted Audlted 30.Sep-26 31-Mar-26 ASSETS 1 Non{urrent assets Property, plant and equipment 83.05 88.28 Ca pital wo rk-in-p rogress 285.63 174.73 Investment property 0.00 0.00 Goodwill 0.00 0.00 Other intangible assets 0.00 0.00 Intangible assets under development a.00 0.00 Biologjcal assets other than bearer plants 0.00 0.00 Investments accounted for using equity method 0.00 0.00 Non-cui.rent financial assets 368|L68 Z63.02 Non-current investments 35.45 35.48 Trade receivables, non<urrent 0.00 0.00 Loans, non{urrent 0.00 0.00 Other nan-current financial assets 8.64 7.66 Total Nomcurrent flnancial assets 44.09 43.14 Deferred tax assets (net) 0.00 a.00 Other non{urrent assets 0.00 0.00 Total Nan-current Assets 41Z.77 306.16 2 Current assets Inventories 51.68 92.32 Current financial assets Current investments 379.51 409.51 Trade receivables, current 82.01 100.77 Cash and cash equivalents 22.69 14.56 Bank balance other than cash and cash equivalents 241.36 255.84 Loans, current 144.02 78.08 Other current financial assets 1.81 3.14 Total current financial assets 871.40 861.89 Current tax assets (net) 0.00 0.00 Other current assets ( DEPOSITS) 0.00 0.00 • Total current Assets 923.08 954.21 3 Nan-current assets classified as held for sale 0.00 0.00 Regulatory deferral account debit balances and related deferred tax Assets 0.00 0.00 TOTAl. ASSETS 1335.85 1260.37 EQLJITI ES AN D llABIllTIES 1 Equity Equity attributable to o`^/ners of Parent Equity share capital 299.03 299.03 Other equi [Showing first 8,000 characters — download PDF for full document]